Institutional Ownership Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE). We have compiled data on the 195 institutions that hold shares in the stock, with a total of 46.5 Million shares, which have been reported (via 13F filing form) to have a value of $341 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
403,753
shares
|
$2.96 Million
0.0% of portfolio
|
Q3 2024
Added 330.3%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
345,000
shares
|
$2.53 Million
0.01% of portfolio
|
Q3 2024
Added 18.68%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
332,612
shares
|
$2.44 Million
0.0% of portfolio
|
Q3 2024
Added 5.15%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
322,935
shares
|
$2.37 Million
0.01% of portfolio
|
Q3 2024
Reduced 24.87%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
227,476
shares
|
$1.67 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.29%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
220,973
shares
|
$1.62 Million
0.0% of portfolio
|
Q3 2024
Added 71.64%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
213,980
shares
|
$1.57 Million
0.0% of portfolio
|
Q3 2024
Reduced 22.09%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 12, 2024 Q3 2024 |
175,661
shares
|
$1.29 Million
0.02% of portfolio
|
Q3 2024
Reduced 44.28%
|
|
|
Hrt Financial LP
New York, NY |
Nov 12, 2024 Q3 2024 |
172,051
shares
|
$1.26 Million
0.01% of portfolio
|
Q3 2024
Added 44.18%
|
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
171,293
shares
|
$1.26 Million
0.12% of portfolio
|
Q3 2024
Reduced 26.69%
|
|
|
Pinnacle Associates LTD
|
Oct 25, 2024 Q3 2024 |
168,573
shares
|
$1.24 Million
0.02% of portfolio
|
Q3 2024
Reduced 42.52%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
167,436
shares
|
$1.23 Million
0.0% of portfolio
|
Q3 2024
Added 19.97%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
165,190
shares
|
$1.21 Million
0.0% of portfolio
|
Q3 2024
Reduced 29.41%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
161,796
shares
|
$1.19 Million
0.0% of portfolio
|
Q3 2024
Reduced 23.99%
|
|
|
Cowen And Company, LLC
|
Nov 12, 2024 Q3 2024 |
161,186
shares
|
$1.18 Million
0.03% of portfolio
|
Q3 2024
Reduced 24.76%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
150,823
shares
|
$1.11 Million
0.0% of portfolio
|
Q3 2024
Reduced 87.43%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
149,114
shares
|
$1.09 Million
0.0% of portfolio
|
Q3 2024
Added 20.98%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
143,034
shares
|
$1.05 Million
0.03% of portfolio
|
Q3 2024
Added 120.58%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
142,694
shares
|
$1.05 Million
0.0% of portfolio
|
Q4 2023
Added 0.93%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
141,936
shares
|
$1.04 Million
0.0% of portfolio
|
Q3 2024
Reduced 54.71%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
136,422
shares
|
$999,973
0.01% of portfolio
|
Q3 2024
Reduced 0.86%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
127,789
shares
|
$936,693
0.0% of portfolio
|
Q3 2024
Added 62.54%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
121,316
shares
|
$889,246
0.01% of portfolio
|
Q3 2024
Added 76.45%
|
|
|
Assenagon Asset Management S.A.
|
Jan 14, 2025 Q4 2024 |
120,723
shares
|
$884,899
0.0% of portfolio
|
Q4 2024
Reduced 35.11%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
120,399
shares
|
$882,524
0.0% of portfolio
|
Q3 2024
Reduced 20.05%
|